Efecto de Una intervención Multidisciplinaria de Estilo de Vida Sobre el Exposoma de Pacientes premenopáusicas Con cáncer de Mama Estadios I-III.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 146
- Locations
- 2
- Primary Endpoint
- Minfulness evaluation - Disposition to attention awareness
Study Overview
Brief Summary
Breast cancer is the leading cause of mortality in women worldwide. Latin-American women are diagnosed at younger ages, in advanced stages, and with aggressive molecular subtypes. Lifestyle seems related to these aggressive conditions and worse outcomes. The present study seeks to evaluate the effect of a hybrid multidisciplinary intervention for implementing a healthy lifestyle to modify the personal and internal exposome of young women with breast cancer. This randomized controlled experimental study with two groups:
Group 1: Hybrid multidisciplinary lifestyle education intervention. Group 2: Individualized hybrid multidisciplinary lifestyle interventions. The multidisciplinary lifestyle intervention program includes oncology, nutrition, physiotherapy, and psychology interventions.
Detailed Description
Breast cancer (BC) is a leading cause of death in women worldwide, especially in Latin America, where patients often present with advanced stages of aggressive subtypes of BC at a younger age. The risk of BC depends on various factors, including hormone replacement therapy history, reproductive history, alcohol or tobacco consumption, physical activity, and dietary habits, collectively called exposome. Exposome refers to the exposure to environmental influences and biological responses throughout a person's life from the prenatal stage. It can be influenced by the environment, diet, behavior, and endogenous processes.
External exposome refers to environmental factors such as mental stress, climate, and lifestyle. In contrast, internal exposome are changes within an organism, such as increased stress hormones, inflammatory cytokines, and oxidative stress. Constant exposure to environmental factors, such as an unhealthy lifestyle, can cause cellular damage and contribute to the growth and evolution of tumors. Once cellular damage occurs, internal exposome promotes changes that create a harmful environment, favoring cancer cells to acquire coping mechanisms for stress and drugs, leading to resistance to oncological treatments.
Obesity is part of the personal exposome and can impact the internal exposome, potentially affecting BC patients. A significant percentage of patients diagnosed with BC (70.9%) are overweight or obese at the time of diagnosis. This weight gain usually occurs during systemic treatment, with 25% of patients gaining weight within six months, 32% between 6-12 months, and 20% between 12-18 months after diagnosis. Young women with breast cancer (YWBC) also experience an increase in weight since the initiation of oncological treatment and up to the second year of diagnosis (from 39% at baseline to 46% in two years), highlighting the importance of evaluating the implications of weight gain and whether early intervention would help control the risk factors mentioned earlier. Obesity may also be associated with worse disease-free and overall survival.
Weight gain in patients with BC is often associated with several factors, including systemic treatment, diagnosis at a young age, and lifestyle changes resulting from the disease or treatment. However, reduced physical activity is the primary mechanism underlying weight gain. The combination of chemotherapy and endocrine therapy is linked to higher weight gain, especially in patients who are premenopausal (an increase of up to 24 kg). In contrast, postmenopausal women tend to lose weight.
BC patients have reported experiencing physical symptoms and psychological distress, which can negatively impact their quality of life (QoL). These symptoms can affect their physical functioning, psychological well-being, and social support levels. YWBC is a vulnerable population with specific concerns such as fertility, self-image, QoL, sexuality, and personal goals and experience high anxiety and depression. Maintaining a healthy lifestyle can improve QoL and lead to better prognoses and lower mortality rates. For example, exercise can reduce breast cancer-related death risk by 30% and all-cause death risk by 41%. Patients undergoing oncology treatment face various nutritional challenges that differ based on the type and stage of cancer, and the treatments may worsen these challenges. Early nutritional screening and interventions are crucial in the cancer population, as emphasized in the clinical guidelines (ASPEN/ESPEN).
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 40 Years (Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Women diagnosed with stage I-III BC, confirmed by pathology and image at the INCAN
- •Candidates for multidisciplinary treatment including surgery, chemotherapy, and/or hormonal treatments.
- •Signed the informed consent form
- •Have access to a mobile phone or any electronic device with an active internet connection to receive the program information.
Exclusion Criteria
- •Patients with inflammatory cancer
- •Those with cardiomyopathy or ventricular dysfunction (NYHA >II), arrythmia secondary to left ventricular ejection alterations that requires medication, previous myocardial infarction, or angina pectoris in the last six months
- •Receiving treatment for cardiovascular or cerebrovascular disease, inflammatory bowel disease, malabsorption syndrome, rheumatoid arthritis, lupus, thyroid diseases, or Cushing syndrome
- •Unable to walk for at least 1 km
- •Have cardiovascular, respiratory, or musculoskeletal diseases that impede physical activity
- •Pregnant or breastfeeding
- •Have psychiatric conditions impeding active participation in this protocol
- •Do not understand Spanish
Outcomes
Primary Outcomes
Minfulness evaluation - Disposition to attention awareness
Time Frame: Baseline, 3, 6,12 and 18 months.
Mindful Attention Awareness Scale (MAAS) 1-2: Lack of attention awareness 3: Intermediate attention awareness 4-5: Advance attention awareness 6: Overvalued (questionnaire was notanswered honestly)
Minfulness evaluation - Disposition to mindfulness
Time Frame: Baseline, 3, 6,12 and 18 months.
Cognitive and Affective Mindfulness Scale-Revised (CAMS-R) 1-2: Lack of disposition 3: Intermediate disposition 4: Advance into mindfulness
Anxiety risk evaluation
Time Frame: Baseline, 3, 6,12 and 18 months.
Generalized Anxiety Disorder Assessment (GAD-7) 0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: severe anxiety
Body composition - Body fat
Time Frame: Baseline, 3, 6,12 and 18 months.
To evaluate the Effect of lifestyle intervention on: Body fat percentage (acceptable fat percentage \<31%)
Education and Motivational effectiveness of digital tools.
Time Frame: 3, 6, 12 and 18 months.
To evaluate the motivational and educational effect of a personalized follow-up by phone, Zoom, WhatsApp, or social networks (number of views in videos, number of Zoom sessions, number o WA calls).
Quality of sleep changes
Time Frame: Baseline, 3, 6,12 and 18 months.
Evaluate the quality of sleep changes by Pittsburgh Sleep Quality Index (PSQI). Total Score 0 to 21. Score 0 (No sleep difficulty); Score 1 to7 (mild sleep difficulty); Score 8-14 (moderate sleep dificulty); 15-21 (severe sleep difficulty).
Depression risk evaluation
Time Frame: Baseline, 3, 6,12 and 18 months.
Patient Health Questionnaire (PHQ-9) 1-4 Minimal depression 5-9 Mild depression 10-14 Moderate depression 15-19 Moderately severe depression 20-27 Severe depression
Body composition - Muscle
Time Frame: Baseline, 3, 6,12 and 18 months.
To evaluate the Effect of lifestyle intervention on: Muscle (muscle mass in kg and muscle mass index ≤6.42 kg/m2)
Adoption of healthy lifestyle
Time Frame: Baseline evaluation and final evaluation (18 months).
The patient lifestyle compliance measured by the scores of World Cancer Research Fund (WCRF) / American Institute for Cancer Research (AICR) questionnaire, SCORE ≥ 5
Physical Activity changes
Time Frame: Baseline, 3, 6,12 and 18 months.
Evaluate the changes on physical activitiy by International Physical Activity Questionnaire (IPAQ) score (high: 1500 to 3000 METS per/week; moderate: 600 MET per/week.
Biochemical parameters - Inflammatory cytokines
Time Frame: Baseline, 3, 6,12 and 18 months.
To evaluate the effect of lifestyle intervention on biochemical parameters: Cytokines level
Biochemical parameters - Glucose
Time Frame: Baseline, 3, 6,12 and 18 months.
To evaluate the effect of lifestyle intervention on biochemical parameters: Blood glucose \<135mg/dL
Anthropometric measurements - Waist to hip ratio
Time Frame: Baseline, 3, 6,12 and 18 months.
Changes in: Waist to hip ratio (\<0.8)
Changes on 24-hour reminder
Time Frame: Baseline, 3, 6, 12 and 18 months.
Evaluate the changes on daily nutritional intake (total energy, carbohydrate, protein and, lipids grams)
Minfulness evaluation - How having a concentrated mind affects on daily life
Time Frame: Baseline, 3, 6,12 and 18 months.
Five Facet Mindfulness Questionnaire (FFMQ) 1-2: Lack of concentrated mind 3: Intermediate attention awareness 4-5: Advance attention awareness
Anthropometric measurements - Body weight
Time Frame: Baseline, 3, 6,12 and 18 months.
Changes in: Body weight (kg)
Biochemical parameters - Lipid profile
Time Frame: Baseline, 3, 6,12 and 18 months.
To evaluate the effect of lifestyle intervention on biochemical parameters: LDL\<100mg/dL, HDL \>40mg/dL and triglycerides \<150mg/dL)
Anthropometric measurements - Waist circumference
Time Frame: Baseline, 3, 6,12 and 18 months.
Changes in: Waist circumference (cm)
Secondary Outcomes
- Improvement of quality of life parameters with lifestyle intervention- QLQ-BR23(Baseline, 3, 6 ,12 and 18 months.)
- Improvement of quality of life parameters with lifestyle intervention- QLQ-C30(Baseline, 3, 6 ,12 and 18 months.)
- Barriers and challenges to implement the lifestyle intervention - CFIR(3, 6, 12 and 18 months.)
- Barriers and challenges to implement the lifestyle intervention - RE-AIM(3, 6, 12 and 18 months.)
Investigators
Marlid Cruz Ramos
PhD
Instituto Nacional de Cancerologia de Mexico
